How 2 Halifax pro athletes balance parenthood with sport
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
National Post
7 hours ago
- National Post
Another sex toy gets thrown onto court during WNBA game
CHICAGO — A sex toy was tossed onto the court during a WNBA game for the second time this week. Article content Video showed the sex toy out of bounds under a basket after a whistle was blown to stop play during the third quarter of the Golden State Valkyries' 73-66 victory over the Chicago Sky. An official then kicked it aside before it was picked up and removed. Article content Article content #Breaking: Another Sex Toy Thrown onto the Court During #WNBA Game #ChicagoSky #Valkyries — The Ball Out (@theballoutmedia) August 2, 2025 Article content Article content 'It's super disrespectful,' Sky centre Elizabeth Williams said in the postgame press conference. 'I don't really get the point of it. It's really immature. Whoever is doing it needs to grow up.' Article content stop throwing dildos on the court… you're going to hurt one of us. — Sophie Cunningham (@sophaller) August 2, 2025 Article content 'I mean, first of all, it was super dangerous,' Valkyries forward Cecilia Zandalasini said after Tuesday's game. 'And then when we found out what it was, I guess we just started laughing. I've never seen anything like that. I'm just glad we worked through that situation. We stayed locked in, we stayed concentrated.' Article content — Isabelle Harrison (@OMG_itsizzyb) August 2, 2025
Globe and Mail
8 hours ago
- Globe and Mail
Kansas City Royals victorious over Blue Jays 9-3 after Mike Yastrzemski hits home run
Mike Yastrzemski homered in his first at-bat with Kansas City, Michael Wacha limited Toronto to a run in eight innings in his longest outing of the season and the Royals beat the Blue Jays 9-3 on Friday night. Acquired from San Francisco just before the trade deadline Thursday, Yastrzemski had a two-run shot off Kevin Gausman (7-8) in the second inning to make it 2-1. Wacha (5-9) allowed three hits and stuck out five, helping the Royals improve to .500 for the first time since June 20. He gave up one run for the fourth consecutive start. Bobby Witt Jr., Salvador Perez and Adam Frazier also homered for Kansas City. Vladimir Guerrero Jr. had two-out homer in the first inning to give Toronto a 1-0 lead. After Yastrzemski gave the Royals the lead in the second, and Witt's three-run homer made it 5-1 in the third. Kansas City added four runs in the ninth. Perez and Frazier homered and Maikel Garcia had a bases-loaded single. Addison Barger hit a two-run homer for Toronto in the ninth. Yastrzemski wasted no time getting his first big hit for Kansas City, hitting the two-run homer in the second inning. The Royals scored five or more runs for the eighth time in 13 games since the All-Star break. Kansas City LHP Noah Cameron (5-4, 2.44 ERA) was set to start Saturday against Toronto RHP Max Scherzer (1-1, 4.89).
Globe and Mail
10 hours ago
- Globe and Mail
Why Novo Nordisk Stock Bumped Higher on Friday
Key Points The Federal government might boost its support of weight-loss drugs soon. According to a media report, it's contemplating a five-year, experimental program that would subsidize their costs for qualifying patients. 10 stocks we like better than Novo Nordisk › Unexpected news of a potential support program from the federal government boosted the share prices of weight-loss drug developers on Friday. The poster boy for that still rather small group, Wegovy/Ozempic maker Novo Nordisk (NYSE: NVO), understandably saw a stock price lift that day. It rose by more than 2%, contrasting well with the 1.6% slide of the S&P 500 index. Federal help for obesity drugs? That news came from The Washington Post, which published an article stating that the Trump administration is planning an experimental program that would cover the costs of such medications. Citing documents from the Centers for Medicare and Medicaid Services (CMS) it had obtained, the newspaper said the plan would be implemented by state Medicaid administrations. It would also be utilized by Medicare Part D insurance plans. These entities would be allowed to cover weight-loss drugs for qualifying patients. At the moment, Medicare generally covers such treatments for patients who suffer from type 2 diabetes. Both Novo Nordisk's Wegovy and rival Eli Lilly 's Zepbound are essentially versions of predecessor diabetes drugs. Some private insurance plans cover obesity medications. The Post wrote that the experimental program will last for five years. Massive potential impact Novo Nordisk hasn't yet commented on the article, but we can be sure the company is excited about the prospect. Combined, Medicare and Medicaid are immense programs. Even if only a few states are willing to cover weight-loss treatments through them, the company could experience a surge in sales. For the stock's investors, this is a potentially very impactful development well worth monitoring. Should you invest $1,000 in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025
